Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
Mumps reemergence has been reported in developed countries with high levels of two-dose mumps-containing vaccine (MuCV) coverage. The effectiveness of the two-dose MuCV may be compromised by limitations in the persistence of immunity. This prospective cohort study evaluated the persistence of immuni...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2023-01-01
|
| シリーズ: | Human Vaccines & Immunotherapeutics |
| 主題: | |
| オンライン･アクセス: | http://dx.doi.org/10.1080/21645515.2023.2166758 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|